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Introduction
Preeclampsia and intrauterine growth restriction (IUGR), as 
well as related perinatal death or preterm birth before the 32nd 
week of pregnancy, are very closely related with the underly-
ing potential placental pathology. In the last 25 years, many 
studies have been conducted regarding the early recogni-
tion of placental insufficiency. Doppler flow measurements 
of uterine and umbilical arteries, as well as maternal serum 
alpha fetoprotein (AFP) and human chorionic gonadotropin 
(hCG) levels, during the first and second trimesters of preg-
nancy are most frequently studied to predict placental insuf-
ficiency and its effects on the fetus (1).
Uterine artery Doppler velocimetry results have demonstrated 
that hemodynamic changes detectable in the uterine artery 
as early as in the first trimester of pregnancy are associated 
with an increased risk of preeclampsia and IUGR (2-4). This 
association can also be demonstrated in the second and third 
trimesters (5-7).
Several studies have recently shown that low serum levels of 
pregnancy-associated plasma protein A (PAPP-A) might be as-
sociated with poor pregnancy and poor neonatal outcomes 
(1, 8, 9). PAPP-A, which was first purified from the serums 
of pregnant women in 1974, is a member of the metzincin 
family of metalloproteinases (10, 11). PAPP-A is an insulin-like 
growth factor-binding protein (IGFBP)-specifically, a protease. 
IGFBPs bind to insulin-like growth factor (IGF) 1 and 2 and 
disconnect these proteins from cell surface receptors; thus, 
low levels of serum PAPP-A are associated with low levels of 
bioactive IGF (11).
A low level of maternal serum PAPP-A is an important sign of 
early placental insufficiency in the first three months of preg-
nancy; however, the effects on the fetus reaches recognizable 
levels in the second trimester. Nevertheless, growth restriction 
determined in the second trimester is also directly associated 
with poor pregnancy and poor neonatal outcomes. Detailed ul-
trasonography for fetal biometric measurements (FBMs) and 
Doppler flow measurements that would be performed in the 
second trimester in patients with low levels of serum PAPP-A, 
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which is measured routinely within the scope of first-trimester 
aneuploidy screening at the 11th–14th weeks of pregnancy may be 
beneficial in predicting poor pregnancy and poor neonatal out-
comes and in taking necessary measures (12, 13).
The present study aimed to determine the predictive value of 
maternal serum PAPP-A levels measured in the first trimester, 
uterine artery Doppler velocimetry performed during the sec-
ond trimester, and FBMs in the second and third trimesters 
for poor pregnancy and poor neonatal outcomes in pregnant 
women.
Material and Methods
This prospective cohort study was conducted in a single uni-
versity-based pregnancy clinic in the Department of Gynecol-
ogy and Obstetrics in Turkey between July 2013 and July 2015, 
with approval of the hospital ethics committee. The singleton 
pregnant women, who presented to our pregnancy clinic, were 
enrolled into the study from September 2013 to May 2015 after 
their informed consents were obtained. The study complied 
with the Declaration of Helsinki and ethical standards. Pregnant 
women were excluded from the final analyses if they missed 
follow-up visits or had complicated pregnancies, such as abor-
tion or iatrogenic termination of the pregnancy.
The women included in the study were followed up after the 
confirmation of pregnancy until delivery. Initially, all the study 
participants underwent the first-trimester aneuploidy screen-
ing test at the 11th–14th weeks of pregnancy, including ma-
ternal serum PAPP-A, β-hCG, and nuchal translucency mea-
surements. Subsequently, color pulsed Doppler ultrasound 
examination of the bilateral uterine arteries was performed at 
the 15th–18th weeks of pregnancy. The women with diastolic 
notches, unilateral or bilateral, in the uterine artery Doppler 
waveforms were recorded. The pulsatility index (PI) and resis-
tance index (RI) of both uterine arteries were measured and 
their arithmetic means were calculated. FBMs, including fetal 
biparietal diameter (BPD), head circumference (HC), femur 
length (FL), and abdominal circumference (AC), were mea-
sured at the 20th–24th and 28th–32nd weeks of pregnancy, and the 
HC/AC ratio was calculated. Poor pregnancy outcomes, such 
as pregnancy-induced hypertension, preeclampsia, and pre-
term birth, and poor neonatal outcomes as well as birthweight 
measured at delivery were noted. Women were divided into 
two groups according to the pregnancy or neonatal outcomes: 
the group with and the group without poor outcomes. These 
two groups were compared with each other with respect to 
the test results specified above, in order to determine the pre-
dictive values of the analyses.
All the clinic-demographic characteristics and test results were 
recorded in a prospectively formed electronic database. All the 
ultrasonographic measurements were performed by the same 
physician, using color Doppler ultrasound (Voluson 730 Expert, 
General Electric Healthcare; Chicago, USA) and the data were 
assessed by a single researcher.
Pregnant women were considered to be under risk of early-on-
set IUGR when the estimated gestational age according to the 
ultrasonographic FBMs at the 20th–24th and 28th–32nd weeks of 
pregnancy was more than one-week behind the gestational age 
calculated according to the last menstrual period (LMP) and 
when HC/AC ratio was over 1.15 and 1.10 at the 20th–24th and 
28th–32nd weeks of pregnancy, respectively (12, 13). This group 
was compared with the group of pregnant women in whom the 
estimated gestational age according to the FBMs was consistent 
with the gestational age calculated according to the LMP, with 
respect to the test results as well as pregnancy outcomes, in-
cluding the birth weight.
Pregnancy-induced hypertension (PIH) was diagnosed if the 
arterial blood pressure of the patient was 140/90 mmHg and 
higher, whereas the diagnosis of preeclampsia was made if a 
high blood pressure was accompanied by proteinuria ≥300 mg 
in 24 hours (14). Birth before the 37th week of pregnancy was 
considered as a preterm birth. The threat of preterm labor was 
diagnosed when there were regular uterine contractions (4 per 
20 minutes) without any cervical dilatation before the 37th week 
of pregnancy. Preterm premature rupture of the membranes 
(PPROM) was defined as rupture of the membranes before 
the onset of labor before the 37th week of pregnancy. Low birth 
weight was defined as a birth weight <2500 g.
A prospective cohort study design was chosen to conduct the 
study in order to minimize a potential bias that could result from 
the nature of the trial. In addition, ultrasonographic measure-
ments and the data assessment were performed by two differ-
ent researchers.
Data were analyzed by Chi-square, Mann–Whitney U test, and 
Student t-test using SPSS (Statistical Package for Social Scienc-
es version 15.0, SPSS Inc.; Chicago, USA) program. A value of 
p<0.05 was considered as statistically significant. The param-
eters assumed to predict pregnancy outcomes were evaluated 
by receiver operating characteristic (ROC) curves.
Results
A total of 175 singleton pregnant women were enrolled in the 
study. Of these pregnancies, three were terminated due to 
missed abortion and one was terminated due to Trisomy 21. 
Thirteen patients were lost to follow-up at different phases of 
the study. The remaining 158 patients formed the study group. 
Table 1 summarizes the clinicodemographic characteristics of 
the study participants. Over the course of the follow-up period, a 
total of 17 (10.75%) pregnant women were determined to have 
at least one of the poor pregnancy outcomes (Table 2).
An ROC curve generated for the first-trimester maternal serum 
PAPP-A values is presented in Figure 1. Considering the cut-off 
value as a 0.72 multiple of the median (MoM), (Standard Error, 
SE: 0.039) (95% CI 0.646–0.798), the sensitivity, specificity, posi-
tive predictive value (PPV), and negative predictive value (NPV) 
achieved for the poor pregnancy outcomes were 82.4%, 29.8%, 
67%, and 56%, respectively.
In the ROC curve analysis of the arithmetic mean of PI of the 
right and left uterine arteries (UAPImean), the cut-off value was 
considered to be 1.08 with 58.8% sensitivity, 48.2% specificity, 
76% PPV, and 55% NPV for poor pregnancy outcomes (Standard 
Error, SE: 0.039) (95% CI 0.646–0.798) (Figure 2). Pregnancy out-
comes were compared between the two groups formed based 
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on this cut-off value; however no statistically significant differ-
ence was determined (p=0.582) (Table 3). After calculating 
the UAPImean for each pregnant woman, the mean value of 
the entire group was calculated as 1.18. The entire group was 
divided into two subgroups according to the UAPImean value: 
≤1.18 or ≥1.19. There was no statistically significant difference 
between the two subgroups in terms of poor pregnancy out-
comes (p=0.723), but the mean birth weights showed a signifi-
cant difference (p=0.025), being lower in the subgroup with an 
UAPImean of ≥1.19 than that of the subgroup with an UAPIme-
an ≤1.18 (Table 4).
The mean RI (UARImean) value of both uterine arteries was 
calculated for each pregnant woman, and then an ROC curve 
was drawn (Figure 3). The sensitivity, specificity, PPV, and NPV 
values for the poor pregnancy outcomes were 58.8%, 34%, 36%, 
and 47%, respectively, when the cut-off value was taken as 0.582 
(Standard Error, SE: 0.039) (95% CI 0.646–0.798). After calculat-
Table 1. Clinicodemographic characteristics of the study 
participants (n=158)
Characteristics Descriptive values Additional
 (mean±SD or n) explanation
Age 27.9±4.4 years Range: 17–41
Weight 62.8±10.1 kg Range: 42–108
Smoking 8 women (5.06%) 2–8 cigarettes day
First pregnancy 64 women (40.5%) -
Previous poor pregnancy 18 women (11.4%) PIH, Preeclampsia, GDM, 
outcome  Preterm birth, PPROM,  
  IUGR, Trisomy 21, 
  Fetal anomaly
Concomitant disease 13 women (8.2%) Hypo-hyperthyroidism, 
  FMF, Psoriasis, Cardiac
  valve diseases, Chronic  
  HT, 
  Asthma, Thalassemia  
  carrier
Medications 7 women (4.4%) Levothyroxine,  
  Colchicine,
  Alfa methyldopa
PIH: pregnancy-induced hypertension; GDM: gestational diabetes mellitus; 
PPROM: preterm premature rupture of the membranes; IUGR: intrauterine 
growth restriction; FMF: familial Mediterranean fever; HT: hypertension
Table 2. Numeric and proportional distribution of poor 
pregnancy outcomes determined during follow-up
Outcomes Number of patients Percentage (%)
 (n=17) (n=158)
PIH/Preeclampsia 5 (3/2) 3.16
Threat of preterm labor 1 0.63
PPROM 4 2.53
Preterm birth <37th week 14 8.86
Preterm birth <32nd week - -
Need for neonatal intensive care 7 4.43
Low birth weight 7 4.43
Placental abruption (ablatio - - 
placentae) 
PIH: pregnancy-induced hypertension; PPROM: preterm premature rupture of 
the membranes
Table 3. Comparison of pregnancy outcomes between two 
subgroups formed according to the cut-off value of UA-
PImean determined by the ROC curve analysis
 Number of patients Percentage (%)
Outcomes (n=17) (n=158)
<1.08 (n=75) 7 (9.3%) 68 (90.7%)
≥1.08 (n=83) 10 (12%) 73 (88%)
∗Chi-square test: p=0.582.
UAPImean: arithmetic mean of the pulsatility indices of the right and left uterine 
arteries; ROC curve: receiver operating characteristic curve
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Figure 1. ROC curve for maternal serum PAPP-A level
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Figure 2. ROC curve for UAPImean
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ing the UARImean for each pregnant woman, the mean value 
of the entire group was calculated as 0.62 and the entire group 
was divided into two subgroups according to the UARImean val-
ues: ≥0.62 or <0.62. No statistically significant difference was 
determined between the two subgroups in terms of pregnancy 
outcomes (p=0.797), while the mean birth weight was signifi-
cantly higher in the subgroup with UARImean <0.62 than that of 
the subgroup with an UARImean of ≥0.62 (p=0.013) (Table 5).
There was no significant difference between the women with 
unilateral uterine artery notch and the women with bilateral 
uterine artery notch in terms of pregnancy outcomes.
Receiver operating characteristic curves were drawn for HC/AC 
ratio measured at the 20th–24th and 28th–32nd weeks of pregnancy 
(Figure 4, 5, respectively). Taking the cut-off value of HC/AC ratio 
as 1.135 for the 20th–24th weeks of pregnancy (Standard Error, 
SE: 0.039) (95% CI 0.646–0.798), the sensitivity, specificity, PPV, 
and NPV for poor pregnancy outcomes were 58.8%, 49.6%, 56%, 
and 49%, respectively. The cut-off value of HC/AC ratio for the 
28th–32nd weeks of pregnancy was taken as 1.075 (Standard Er-
ror, SE: 0.039) (95% CI 0.646–0.798) with 52.9% sensitivity, 41.1% 
specificity, 59% PPV, and 67% NPV.
Pregnant women considered to be under the risk of early-onset 
IUGR (inconsistent FBMs subgroup), as specified in the Material 
and Methods section, were compared with the pregnant wom-
en with whom the estimated gestational age according to the 
fetal biometric measurement was consistent with the gestation-
al age calculated according to the last menstrual period (consis-
tent FBMs subgroup), in terms of the pregnancy outcomes and 
birth weight (Table 6). Statistically significant differences were 
Table 4. Comparison of pregnancy outcomes and birth weight between two subgroups formed according to the UA-
PImean of the entire group
                                      Pregnancy outcome*   Birth weight (g) 
                                      (n=158)   (n=158)
 Poor Not poor 
UAPImean (n=17) (n=141) Mean±SD** Median Range
≤1.18 (n=90) 9 (10%) 81 (90%) 3320.2±411.1 3350 2400–4105
≥1.19 (n=68) 8 (11.8%) 60 (88.2%) 3165.7±445.8 3145 1860–4600
*Chi-square test: p=0.723 for comparison of the pregnancy outcomes between the two subgroups.
**T-test: p=0.025 for comparison of the mean birth weight between the two subgroups.
UAPImean: arithmetic mean of the pulsatility indices of the right and left uterine arteries; SD: standard deviation 
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Figure 3. ROC curve for UARImean
ROC Curve
Spesificity
Se
ns
iti
vi
ty
0.0 0.2 0.4 0.6 0.8 1.0
1.0
0.8
0.6
0.4
0.2
0.0
Figure 5. ROC curve for HC/AC ratio measured at the 28th–32nd 
weeks of pregnancy
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Figure 4. ROC curve for HC/AC ratio measured at the 20th–24th 
weeks of pregnancy
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determined between the two subgroups in terms of pregnancy 
outcomes (p=0.045) and birth weight (p=0.011).
Discussion
Impaired placentation is one of the most important causes 
of poor pregnancy outcomes for mother and/or the baby. Re-
searches on the etiology of unpleasant outcomes of pregnancy, 
such as preeclampsia, IUGR, and preterm birth, highlight the 
importance of normal placental development. Markers that 
could indicate these changes prior to the onset of disorder will 
provide us a chance to take early preventive measures and even 
to prevent this in the future. For this reason, the world of perina-
tology has carried out many studies, particularly in recent years, 
on numerous placental biochemical markers, various Doppler 
ultrasound techniques and parameters, and various ultrasono-
graphic methods to evaluate fetal and placental development 
in order to determine placental defects (1, 8, 10, 11). We aimed 
to determine the predictive value of the maternal serum PAPP-
A level of the first trimester, uterine artery Doppler velocimetry 
of the second trimester, and FBMs of the second and third tri-
mester for poor pregnancy and poor neonatal outcomes which 
would probably occur due to placentation defect in pregnant 
women, and we found that the early prediction of unfavorable 
maternal and unfavorable neonatal outcomes of placental in-
sufficiency might be possible using some test results, such as 
FBMs or an assessment of the HC/AC ratio, even though there is 
no method that can be used alone as a screening test.
The association between low hCG (<0.5 MoM) and PAPP-A 
(<0.4 MoM) levels, which are measured on the 10th–14th weeks 
of pregnancy, and the complications of pregnancy has been 
demonstrated previously (15, 16). In the present study as well, 
poor pregnancy outcomes could be predicted with 82.4% sen-
sitivity and 29.8% specificity when the cut-off value was taken 
as 0.72 MoM in the ROC curve drawn for PAPP-A, which was 
measured in the 11th–14th weeks of pregnancy.
Doppler ultrasonography of the uterine arteries is the other 
method used for the early prediction of pathological placenta-
tion and can be performed at various weeks of pregnancy. In 
the present study, a Doppler ultrasound of uterine arteries was 
performed on the 15th–18th weeks of pregnancy, the mean PI 
value of both sides was calculated (UAPImean), and then an 
ROC curve was drawn. We achieved a sensitivity of 58.8% and a 
specificity of 48.2% for poor pregnancy outcomes when the cut-
off value was taken as 1.08. The average value of the entire group 
of pregnant women for UAPImean was found to be 1.18±0.40, 
with no significant difference determined between pregnancy 
outcomes when the group was divided into two based on this 
value. However, a statistically significant difference was deter-
mined in terms of the mean birth weight (p=0.025). The results, 
thus, indicate that increased uterine artery PI might cause a de-
crease in birth weight. Cooper et al. (17) conducted a study in 
229 pregnant women and underlined the value of an increased 
mean uterine artery PI measured at the 22nd week of pregnancy 
in predicting preterm birth, the small for gestational age (SGA), 
and a low birth weight, particularly in pregnant women with a 
PAPP-A value lower than 0.4 MoM. Pilalis et al. (18) evaluated 
878 pregnant women on the 11th–14th weeks of pregnancy and 
emphasized that each of the Doppler ultrasound of uterine arter-
ies and the PAPP-A value is an independent factor for predicting 
SGA and that the combination of both is more effective for pre-
diction. The present study, showing an inverse relation between 
uterine artery PI and birth weight, differs from the other studies 
in that uterine artery PI has been evaluated within a different 
gestational age period of pregnancy. Nevertheless, it is neces-
sary to underline that a normal PI does not exclude obstetric 
complications, as was demonstrated in almost all studies.
RI is another parameter assessed by Doppler ultrasound of the 
uterine arteries. In the present study, the mean RI of the uterine 
arteries (UARImean) was calculated for each pregnant woman 
and then an ROC curve was drawn. We were able to predict 
poor pregnancy outcome with 58.8% sensitivity and 34% speci-
ficity when the cut-off value was taken as 0.582. The average 
Table 6. Comparison of pregnancy outcomes and birth weight between two subgroups formed according to fetal biometric 
measurements
UAPImean                                      Pregnancy outcome*   Birth weight (g) 
                                      (n=158)   (n=158)
 Poor Not poor 
 (n=17) (n=141) Mean±SD** Median Range
Consistent (n=130) 11 (8.5%) 119 (91.5%) 3292.1±440.7 3313.5 1860–4600
Inconsistent (n=28) 6 (21.4%) 22 (78.6%) 3075.7±341.1 3110 2500–3740
*Chi-square test: p=0.045 for comparison of the pregnancy outcomes between the two Subgroups.
**Mann–Whitney U test: p=0.011 for comparison of the mean birth weight between the two Subgroups. 
Table 5. Comparison of pregnancy outcomes and birth 
weight between two subgroups formed according to the 
UARImean of the entire group
                            Pregnancy outcome* Birth weight  (g)** 
                         (n=158)  (n=158)
 Poor Not poor  
UARImean (n=17) (n=141) Mean±SD**
<0.62 (n=79) 8 (10.1%) 71 (89.1) 3338.3±413.5
≥0.62 (n=79) 9 (11.4%) 70 (%88.6) 3169.1±435.8
*Chi-square test: p=0.797 for comparison of the pregnancy outcomes between 
the two subgroups.
**T-test: p=0.013 for comparison of the mean birth weight between the two 
subgroups.  
UARImean: arithmetic mean of the resistance indices of the right and left 
uterine arteries
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value of UARImean was calculated for the whole group and the 
group was divided into two according to this value (0.62±0.10). 
We failed to determine a significant difference between the 
groups in terms of obstetric complications; however, there was 
significant difference between the mean birth weights of the 
groups (p=0.013). This result suggests that increased uterine 
artery RI, as well as increased PI, might cause a decrease in 
birth weight. The literature includes studies propounding that 
increased uterine artery RI and uterine notch can predict pre-
eclampsia and SGA (19, 20). In these studies, which were per-
formed in large population groups and usually in the 18th–24th 
weeks of pregnancy, the sensitivity reached 63–95% when RI 
was above the 95th percentile or when the limit values of 0.56–
0.58 were used for RI (21, 22). The RI found in the present study 
is close to those determined in earlier studies, although the cut-
off value 0.582 was measured in a different gestational age pe-
riod of pregnancy. The present study found no significant differ-
ence between the women with unilateral uterine artery notch 
and the women with bilateral uterine artery notch in terms of 
pregnancy outcomes.
Ultrasonographic biometry has always been an important 
tool in monitoring fetal development. In the present study, the 
pregnant women with whom estimated gestational age that 
was calculated based on ultrasonographic FBMs performed at 
the 20th–24th and 28th–32nd weeks of pregnancy was more than 
1 week behind the gestational age calculated according to the 
last menstrual period and the pregnant women with an HC/
AC ratio over 1.15 and 1.10 at the 20th–24th and 28th–32nd weeks 
of pregnancy, respectively, were considered to be under a 
risk of early onset fetal growth restriction. This high-risk group 
was compared with the other group of pregnant women and 
statistically significant differences were determined in terms 
of pregnancy outcomes (p=0.045) and mean birth weight 
(p=0.011). In the literature, studies on this subject are not so 
many, excluding two separate studies conducted by Fox et al. 
(12, 13) suggesting an association between a HC/AC ratio >90th 
percentile and poor pregnancy outcomes and the study con-
ducted by Colley et al. (23) determining a weak correlation 
between the HC/AC ratio and the ponderal index. In addition 
to the literature information, the present study indicated that 
it is possible to obtain significant results in terms of pregnancy 
outcomes and birth weight in the light of precise FBMs and an 
assessment of the HC/AC ratio (23, 24).
Our study has some limitations. First, power calculation was not 
performed, and we had a small sample size in terms of the sub-
group with poor pregnancy outcomes. Second, we did not com-
bine the results of the tests to analyze the predictive values of 
the combinations of current biochemical and ultrasonographic 
methods.
In conclusion, we aimed to determine the predictive value of 
maternal serum PAPP-A levels, uterine artery Doppler velocim-
etry, and FBMs for poor pregnancy and poor neonatal outcomes 
in pregnant women and found that serum PAPP-A levels and 
FBMs could be used for predicting pregnancy outcomes, while 
uterine artery Doppler velocimetry and FBMs could be used 
for predicting neonatal outcomes, specifically the birth weight. 
Therefore, an early prediction of unfavorable maternal and neo-
natal outcomes of placental insufficiency might be possible us-
ing some test results, such as FBMs or by the assessment of the 
HC/AC ratio, even though there is no method that can be used 
alone as a screening test. Therefore, different combinations of 
current biochemical and ultrasonographic methods may be 
necessary. It is clear that a screening test including certain com-
binations of biochemical and ultrasonographic markers with 
certain cut-off values, which will be created in multicenter stud-
ies with larger study populations, is needed in the future in order 
to predict obstetric complications earlier.
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